Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

BACKGROUND: The neutrophil to lymphocyte ratio (NLR) is known to be prognostic for patients with advanced cancers treated with immune checkpoint inhibitors (ICI), but has generally been evaluated as a single threshold value at baseline. We evaluated NLR at baseline and within first month during trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingjia, Spakowicz, Daniel, Burkart, Jarred, Patel, Sandip, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Carbone, David P., Verschraegen, Claire F., Presley, Carolyn J., Otterson, Gregory A., Kendra, Kari, Owen, Dwight H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751277/
https://www.ncbi.nlm.nih.gov/pubmed/31367835
http://dx.doi.org/10.1007/s00432-019-02982-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751277/
https://www.ncbi.nlm.nih.gov/pubmed/31367835
http://dx.doi.org/10.1007/s00432-019-02982-4

Ejemplares similares